Modus Therapeutics Holding AB (publ) (OM: MODTX)
Health Care · Biotechnology · SE
Skr0.38
-10.19% today · -74.4% 1Y
Modus Therapeutics Holding AB (publ) (OM: MODTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.40M and employs 2 people.
Over the last twelve months the share price has lost 74.4%, trading between 0.21 and 3.49.
Tweenvest scores Modus Therapeutics Holding AB (publ) across four factors: quality 26/100. Its strongest factor is quality.
MODTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.40M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.23
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- Skr3.49
- 52-week low
- Skr0.21
- Avg volume (3M)
- —
- Shares outstanding
- 121.63M
- Employees
- 2
- Next earnings
- —
About Modus Therapeutics Holding AB (publ)
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.
- Founded
- 2011
- Listed since
- Jul 22, 2021
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.